Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer

Fumihiro Tanaka, Kazue Yoneda, Nobuyuki Kondo, +11

Clinical Cancer Research

Complications associated with endobronchial ultrasound-guided transbronchial needle aspiration: a nationwide survey by the Japan Society for Respiratory Endoscopy

Fumihiro Asano, Motoi Aoe, Yoshinobu Ohsaki, +8

Respiratory Research

Interventional PulmonologyEndoscopic SurgeryJapan SocietyInterventional Endoscopic UltrasoundRespiratory Endoscopy +8

Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial

Lee M. Krug, Hedy L. Kindler, Hilary Calvert, +16

The Lancet Oncology

Surgical OncologyMedicinePrevious ChemotherapyPleural DiseasePlacebo-controlled Trial +5

Frequent inactivation of the <scp><i>BAP1</i></scp> gene in epithelioid‐type malignant mesothelioma

Yoshie Yoshikawa, Ayuko Sato, Tohru Tsujimura, +12

Cancer Science

Malignant MesotheliomasTumor BiologyTumoral PathologyMm SpecimensSomatic Variant +13

AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor

Masayuki Takeda, Tokuzo Arao, Hideyuki Yokote, +9

Clinical Cancer Research

Immunological effects of silica and asbestos.

Takemi Otsuki, Megumi Maeda, Shuko Murakami, +9

PubMed

Mechanisms of Action of the Novel Sulfonamide Anticancer Agent E7070 on Cell Cycle Progression in Human Non-Small Cell Lung Cancer Cells

Kazuya Fukuoka, Jitsuo Usuda, Yasuo Iwamoto, +6

Investigational New Drugs

Tumor BiologyOncologyCell Cycle ProgressionMedicineBronchial Neoplasm +6

Functional Properties of CD8⁺Lymphocytes in Patients with Pleural Plaque and Malignant Mesothelioma

Naoko Kumagai-Τakei, Yasumitsu Nishimura, Megumi Maeda, +6

Journal of Immunology Research

Clinical ImmunologyFunctional PropertiesImmunotoxicologyPleural PlaqueImmune Regulation +19

A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors

Toshio Shimizu, Kazuya Fukuoka, Masayuki Takeda, +8

Cancer Chemotherapy and Pharmacology

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors

Masayuki Takeda, Takayuki Takahama, Kazuko Sakai, +21

The Oncologist